Evidence map›Paper›PMID 38440276›Full record

ArticleRSC advances2024

Scalable synthesis of high-quality, reduced graphene oxide with a large C/O ratio and its dispersion in a chemically modified polyimide matrix for electromagnetic interference shielding applications.

Zahid Mehmood, Syed Aizaz Ali Shah, Saeed Omer, Ramsha Idrees, Shaukat Saeed

Abstract read
In one paragraph

Article in RSC advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zahid MehmoodDepartment of Chemistry, Pakistan Institute of Engineering and Applied Sciences (PIEAS) Islamabad-45650 Pakistan syedaizazalishah@gmail.com shaukat@pieas.edu.pk.ORCID https://orcid.org/0000-0002-1174-8343
Syed Aizaz Ali ShahDepartment of Chemistry, Pakistan Institute of Engineering and Applied Sciences (PIEAS) Islamabad-45650 Pakistan syedaizazalishah@gmail.com shaukat@pieas.edu.pk.ORCID https://orcid.org/0000-0003-4788-2920
Saeed OmerDepartment of Chemistry, Pakistan Institute of Engineering and Applied Sciences (PIEAS) Islamabad-45650 Pakistan syedaizazalishah@gmail.com shaukat@pieas.edu.pk.
Ramsha IdreesDepartment of Chemistry, Pakistan Institute of Engineering and Applied Sciences (PIEAS) Islamabad-45650 Pakistan syedaizazalishah@gmail.com shaukat@pieas.edu.pk.
Shaukat SaeedDepartment of Chemistry, Pakistan Institute of Engineering and Applied Sciences (PIEAS) Islamabad-45650 Pakistan syedaizazalishah@gmail.com shaukat@pieas.edu.pk.ORCID https://orcid.org/0000-0002-8061-1500

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High-purity reduced graphene oxide (RGO or rGO) with appreciable conductivity is a desired conductive filler for lightweight polymer composites used in coatings, electronics, catalysts, electromagnetic interference (EMI) shielding, and energy storage devices. However, the intrinsic conductivity and the uniform dispersion of RGO in relatively polar matrices are challenging, leading to poor overall conductivity and performance of the composite material. The reported study improved the RGO intrinsic conductivity by increasing its C/O ratio while also simultaneously enhancing its compatibility with the polyimide (PI) matrix through ester linkages for better dispersion. A two-step reduction method drastically increased the number of structural defects and carbon content in the resulting RGO, corresponding to a maximum

Identifiers

PMID38440276
PMCPMC10910857

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.